Latest

A-TANGO strives to increase the survival rate with G-TAK – a novel combinatorial therapy, and to decrease the burden on the national healthcare systems, which is caused by a large percentage of patients…

Liver diseases pose a significant global health challenge, with conditions like liver fibrosis often remaining undetected until they reach advanced stages, leading to severe consequences such as cirrhosis and liver cancer. In…

Liver diseases pose a significant global health challenge, with conditions like liver fibrosis often remaining undetected until they reach advanced stages, leading to severe consequences such as cirrhosis and liver cancer. In…

DECISION strives to better understand the pathophysiology of decompensated cirrhosis leading to acute-on-chronic liver failure (ACLF) at the systems level by taking advantage of already existing large and clinically well-characterized patient cohorts.…

Amsterdam, May 2, 2024 – New evidence reveals global underassessment and undertreatment of chronic hepatitis B (HBV), especially among women and Asian minorities in the West, a new study in the Journal of…

The liver community mourns the loss of Dr. Stephen Harrison, a visionary in MASLD clinics and clinical research, whose contributions have shaped the current state of the field. Dr. Stephen Harrison was…

EASL is the largest professional body in Europe devoted to liver health. EASL’s overarching goal is to spread knowledge and expertise in best practices and the latest scientific breakthroughs in the field…